Differences between Neisseria gonorrhoeae and Neisseria meningitidis: A Complete Comparison

A microbiologist receives a culture plate from a genital specimen. On Modified Thayer-Martin agar, oxidase-positive Gram-negative diplococci have grown. The question is immediate: is this Neisseria gonorrhoeae — a sexually transmitted pathogen requiring contact tracing — or Neisseria meningitidis, which can occasionally colonise the genitourinary tract and must not be misidentified as gonorrhoea?

The single test that answers this question is maltose fermentation: N. gonorrhoeae ferments glucose only; N. meningitidis ferments both glucose and maltose. This one carbohydrate utilisation result separates the two most clinically important Neisseria species.

Despite sharing morphology, cultural requirements, and oxidase-positive biochemistry, these two organisms cause fundamentally different diseases, occupy different body sites, and require completely different clinical responses. This article provides a systematic comparison of every key property that distinguishes them.

Neisseria gonorrhoeae and Neisseria meningitidis are Gram-negative diplococci (kidney bean-shaped) with flattened sides.  They are characteristically found inside polymorphonuclear leucocytes. These are non-sporing, non-motile, and oxidase positive. They have exacting growth requirements and do not grow on ordinary media. Growth occurs on media enriched with blood or serum like Chocolate Agar, Thayer Martin Agar, and Modified New York City Medium.

The major structural difference between N. meningitidis (meningococci) and N. gonorrhoeae (gonococci) is the presence of a capsule. Meningococci have a thick polysaccharide capsule, whereas gonococci do not. In the laboratory, the differentiation between Neisseria meningitidis and N.gonorrhoeae is made based on sugar fermentation: meningococci ferment maltose whereas gonococci do not.

Complete Comparison: N. gonorrhoeae vs N. meningitidis

Laboratory Identification Workflow

When oxidase-positive GN diplococci grow on Thayer-Martin or chocolate agar from a clinical specimen, the following workflow distinguishes the two species:

Oxidase-positive GN diplococci on MTM/chocolate agar
                    ↓
        Carbohydrate Utilisation Test (CUT)
        or Rapid CUT (RCUT)
                    ↓
    ┌───────────────────────────────────────┐
    │                                       │
Glucose +          Glucose +            Glucose +
Maltose -          Maltose +            Lactose +
    │                   │                   │
N. gonorrhoeae     N. meningitidis      N. lactamica
(genital site)     (any site)           (non-pathogenic)

The maltose result is definitive. No other property reliably separates N. gonorrhoeae from N. meningitidis after Gram stain and oxidase. The colistin resistance property helps explain why both grow on MTM (which contains colistin), but carbohydrate utilisation is the identification standard.

Additional confirmatory methods:

• MALDI-TOF mass spectrometry — fastest and most accurate; identifies to species level in minutes from a colony; now the gold standard in well-resourced labs
• Commercial antigen tests (e.g., Gonogen, Meritec-GC) — rapid agglutination tests using species-specific antibodies; useful in resource-limited settings
• Molecular (NAAT) — PCR from clinical specimens; does not require viable organisms; highly sensitive and specific; does not require culture

How to Remember

The maltose rule — the single most important differentiating test:

Meningococcus ferments Maltose Gonococcus ferments Glucose only

One M matches the other. This is the standard examination question for Neisseria identification and the standard laboratory differentiation test.

The capsule logic: Meningococcus HAS a capsule → serogroups → vaccines possible Gonococcus has NO capsule → pili and Opa variation instead → no effective vaccine

These two facts about the capsule explain: why meningococcal disease can be prevented by vaccination (but gonococcal disease cannot), why meningococcal strains are classified into serogroups (based on capsular polysaccharides) while gonococcal strains are not, and why the two organisms have evolved fundamentally different immune evasion strategies.

Disease site as a memory anchor: Meningococcus = Meningitis = Meninges = CNS Gonococcus = Gonads = Genitourinary tract

The colistin property explained: Both organisms grow on Thayer-Martin agar which contains colistin. Meningococci are intrinsically resistant to colistin (LPS modifications). Gonococci are colistin-sensitive but the colistin concentration in MTM is specifically calibrated to suppress other GN bacteria while not inhibiting gonococci — the MTM selectivity exploits concentration, not intrinsic resistance.

References

1. Tille, P.M. (2017). Bailey and Scott's Diagnostic Microbiology (14th ed.). Elsevier. Bailey & Scott’s Diagnostic Microbiology. Mosby.
2. Tinsley, C.R., & Nassif, X. (1996). Analysis of the genetic differences between N. meningitidis and N. gonorrhoeae. PNAS, 93(20), 11109–11114. https://doi.org/10.1073/pnas.93.20.11109
3. Edwards, J., Quinn, D., Rowbottom, K. A., Whittingham, J. L., Thomson, M. J., & Moir, J. W. (2012). N. meningitidis and N. gonorrhoeae are differently adapted in the regulation of denitrification. Biochemical Journal, 445(1), 69–79. https://doi.org/10.1042/BJ20111984
4. Tzeng, Y.L., & Stephens, D.S. (2000). Epidemiology and pathogenesis of Neisseria meningitidis. Microbes and Infection, 2(6), 687–700.
5. Centers for Disease Control and Prevention. (2021). Sexually Transmitted Infections Treatment Guidelines, 2021: Gonococcal Infections. MMWR, 70(4).